Research published in Chemical Communications, reveals that this new compound could be used in a ’chemically-sensitive MRI scan’ to help identify the extent of progression of diseases such as cancer, without the need for intrusive biopsies. The researchers, who are part of an Engineering and Physical Sciences Research Council (EPSRC) funded ...
The study, published in the August issue of the journal Glycobiology, found that exposing prostate cancer cells to pectin under laboratory conditions reduced the number of cells by up to 40 percent. UGA Cancer Center researcher Debra Mohnen and her colleagues at UGA, along with Vijay Kumar, chief of research ...
Animal studies have shown that DIM -- a chemical produced when vegetables such as broccoli, cabbage and kale are chewed and digested -- can actually stop the growth of certain cancer cells. (Credit: iStockphoto) Veggie fans can already point to some cancer-fighting properties of ...
Since the introduction of PSA (prostate specific antigen) testing in the late 1980s, the incidence of prostate cancer has risen dramatically. The rise is mainly due to widespread screening of asymptomatic men. Screening for prostate cancer is a controversial issue because evidence is lacking that PSA screening prevents prostate cancer ...
Cancer deaths are largely attributed to tumor metastasis--when the cancer cells spread to other parts of the body--rather than primary tumors. Previous research has shown that OGR1 is expressed at lower levels in metastases than in primary prostate tumors. Lisam Shanjukumar Singh, Ph.D., of Indiana University in Indianapolis and colleagues ...
The study involved male mice that were fed a plant compound found in red wine called resveratrol, which has shown anti-oxidant and anti-cancer properties. Other sources of resveratrol in the diet include grapes, raspberries, peanuts and blueberries. In the study resveratrol-fed mice showed an 87 percent reduction in their risk of ...
Reconstructive urologist Dr. Allen Morey (right) suggested a new type of male sling procedure to improve urinary control for prostate-cancer survivor Michael Yarborough. (Credit: UT Southwestern Medical Center) "After surgery to remove the cancer, I started experiencing incontinence," said Mr. Yarborough, who operates a ...
A study this year found no association between childhood obesity and 100 percent fruit juice with no sugar added. “That’s big news, and it’s made a difference in what I tell my patients,” says Rockwell, D.O., assistant professor in the Department of Family Medicine at the University of Michigan ...
A new study from the Southwest Oncology Group strongly suggests that for men at risk of the disease -- which strikes one in six men -- finasteride also raises the odds that physicians will find fast-growing prostate cancers early, when they are most easily treatable. "It appears that a man concerned ...
Lead investigator Akhouri Sinha, a professor of genetics, cell biology, and development and research scientist at the Minneapolis VA Medical Center, said the belief that black men’s tumors are more aggressive is based on studies that failed to match patients properly and used only indirect means to measure tumor aggressiveness. ...
The study of the Prostate Cancer Prevention Trial, led by University of Illinois at Chicago professor of pathology Dr. Peter Gann, is published in the Sept. 12 issue of the Journal of the National Cancer Institute. Co-authors include researchers from Merck & Co. Inc. Merck markets finasteride as Proscar. The Prostate ...
The study found that what really impacted emotional distress - among both patients and their spouses - was whether the patient was newly diagnosed, facing a recurrence or living with advanced disease. Researchers looked at 263 men with prostate cancer and their spouses. Participants were recruited from three large cancer ...
Dr. Robert Timmerman and radiation therapist, Sheree Kincaid, get patient Breihan Bridgewater ready for treatment. (Credit: Image courtesy of UT Southwestern Medical Center) When the 74-year-old semi-retired electronic technician was diagnosed with prostate cancer, the thought of undergoing surgery or having to lie on his ...
Juice from the pomegranate shows promise for fighting prostate cancer. (Credit: USDA Agricultural Research Service) In a new study, Navindra Seeram and colleagues have found that the tart, trendy beverage also uses a search-and-destroy strategy to target prostate cancer cells. In previous research, Seeram’s group ...
While the system, which is made by Nucletron, a technology company based in The Netherlands, is only being used for imaging and planning purposes so far, it ultimately will help with the actual placement of the seeds. To date, Jefferson is the first medical center in the Delaware Valley to ...
Writing in the November 1, 2007 issue of Cancer, Dr. Neil Fleshner and Dr. Alexandre Zlotta from the University of Toronto say that available medications, such as 5-alpha reductase inhibitors and selective estrogen receptor modifiers, show promise in reducing malignancies. In addition, there is strong evidence that dietary fat significantly ...
Although the finding could eventually lead to changes in this standard treatment for a sometimes deadly disease, the Johns Hopkins researchers caution that their discovery is far too preliminary for prostate cancer patients or physicians to stop using it. The therapy is effective at slowing tumor growth, they emphasized. David Berman, ...
PSA velocity has been the subject of much research and debate since the beginning of the PSA screening era. Initially, PSA velocity was proposed for use in men with moderately elevated PSA levels in order to decrease the number of unnecessary biopsies. But often PSA velocity is being used in ...
Apatone was discovered by Dr. Henryk Taper from the Catholic University of Leuven in Brussels, Belgium and was developed by Dr. James Jamison and Dr. Jack Summers, both of Summa Health System, and Dr. Jacques Gilloteaux, now with the American University of the Caribbean in St. Maarten. Their groundbreaking ...
"Our study found that African-American men have a slightly higher risk of what is known as PSA recurrence, which is a blood test that indicates the presence of cancer based on the levels of a certain biomarker known as prostate-specific antigen," said Stephen Freedland, M.D., a urologist at Duke and ...
Androgen deprivation therapy is frequently used to treat high-risk localized prostate cancer. Studies have shown that androgen deprivation therapy, when used with external beam radiation therapy, improves survival in patients with advanced and localized prostate cancer. But the use of androgen deprivation therapy can also lead to the development of ...
Prostate cancer treatments are still being debated because they have not yet been compared in a randomized trial, in which men would be randomly assigned to one treatment or another, according to background information in the article. "Therefore, treatment choice is strongly influenced by patient and physician personal preferences and ...
Danish researchers looked at 62,865 men aged 50 and over, with an average age of just under 67. 15,716 had suffered a fracture of some description and 47,149 formed the non-fracture control group. They discovered that prostate cancer made men 1.8 times more likely overall to suffer a fracture and 3.7 ...
One of the tools used for the diagnosis and treatment of prostate cancer is the Gleason scoring system, which grades adenocarcinomas (malignant tumors) of the prostate based on the patterns of prostatic glands. Many studies have confirmed the prognostic significance of the Gleason score with respect to time to recurrence ...
Brachytherapy is a minimally invasive procedure where a radiation oncologist places small radioactive seeds into the prostate in order to kill the cancer cells. It is an attractive treatment option for patients with prostate cancer because it has a much shorter recovery time than surgery and studies have shown brachytherapy ...
In the Nov. 2 issue of Cell, they report that this protein, known as SENP1 (Sentrin/SUMO-specific protease 1), might provide a basis for future targeted therapies. They have already started to develop an agent to stop SENP1 from working in cells, which could push a tumor to stop growing and ...
The study demonstrated that the greatest benefit of statin medications was observed in patients who had more aggressive or advanced forms of prostate cancer. The research also showed that men who took statins during high-dose radiation therapy had a lower rate of the cancer spreading to distant parts of the ...
"Prostate cancer patients are not routinely advised to exercise. Walking is one tool that prostate cancer patients can use to improve their health and minimize the side effects of cancer and cancer treatments," said Paula Chiplis, PhD., RN, the lead author of the study and a clinical instructor and senior ...
In the past year, using data and methods based on the HapMap, MGH researchers have published new genetic contributors to conditions such as type 2 diabetes, Crohn’s disease, elevated blood cholesterol, rheumatoid arthritis, multiple sclerosis, and prostate cancer. These studies and many others used a suite of analytical methods ...
Multiple fluorescent dyes reveal sites of new bone formation caused by a promising nonsteroidal compound that stimulates bone formation and increases bone density and strength. (Credit: Courtesy of Arjan van Oeveren, Ligand Pharmaceuticals, Inc.) In the report, Arjan van Oeveren and colleagues point out ...